These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 1724898)
1. Keratin 17: a useful marker in anti-psoriatic therapies. de Jong EM; van Vlijmen IM; van Erp PE; Ramaekers FC; Troyanovski SM; van de Kerkhof PC Arch Dermatol Res; 1991; 283(7):480-2. PubMed ID: 1724898 [No Abstract] [Full Text] [Related]
2. Keratin gene expression during the resolution of psoriatic plaques: effect of dithranol, PUVA, etretinate and hydroxyurea regimens. Holland DB; Wood EJ; Cunliffe WJ; Turner DM Br J Dermatol; 1989 Jan; 120(1):9-19. PubMed ID: 2484124 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study on the pattern of 50 kd cytokeratin in psoriasis. Fedi AM; Lotti T; Meo AL; Rizzo A; Leoncini P Int J Dermatol; 1992 Jan; 31(1):30-2. PubMed ID: 1371106 [TBL] [Abstract][Full Text] [Related]
4. DNA content and Ks8.12 binding of the psoriatic lesion during treatment with the vitamin D3 analogue MC903 and betamethasone. de Mare S; de Jong EG; van de Kerkhof PC Br J Dermatol; 1990 Sep; 123(3):291-5. PubMed ID: 1698446 [TBL] [Abstract][Full Text] [Related]
5. Epidermal hyperproliferation assessed by the monoclonal antibody Ks8.12 on frozen sections. de Mare S; Van Erp PE; van de Kerkhof PC J Invest Dermatol; 1989 Jan; 92(1):130-1. PubMed ID: 2462594 [TBL] [Abstract][Full Text] [Related]
6. Epidermal keratin levels during oral 1-alpha-hydroxyvitamin D3 treatment for psoriasis. Holland DB; Wood EJ; Roberts SG; West MR; Cunliffe WJ Skin Pharmacol; 1989; 2(2):68-76. PubMed ID: 2483330 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of calcipotriol ointment applied under hydrocolloid occlusion in psoriasis. Castelijns FA; Gerritsen MJ; van Erp PE; van de Kerkhof PC Dermatology; 2000; 200(1):25-30. PubMed ID: 10681609 [TBL] [Abstract][Full Text] [Related]
8. Effect of calcipotriol on epidermal cell populations in alefacept-treated psoriatic lesions. van Duijnhoven MW; Körver JE; Vissers WH; van Vlijmen-Willems IM; Pasch MC; van Erp PE; Van de Kerkhof PC J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):27-33. PubMed ID: 16405604 [TBL] [Abstract][Full Text] [Related]
9. Monospecific monoclonal antibodies to keratin 1 carboxy terminal (synthetic peptide) and to keratin 10 as markers of epidermal differentiation. Leigh IM; Purkis PE; Whitehead P; Lane EB Br J Dermatol; 1993 Aug; 129(2):110-9. PubMed ID: 7544603 [TBL] [Abstract][Full Text] [Related]
10. Treatment of psoriasis with a new combination of calcipotriol and betamethasone dipropionate: a flow cytometric study. van Rossum MM; van Erp PE; van de Kerkhof PC Dermatology; 2001; 203(2):148-52. PubMed ID: 11586014 [TBL] [Abstract][Full Text] [Related]
11. The potential of the essential fatty acid-deficient hairless rat as a psoriasis screening model for topical anti-proliferative drugs. Jensen M; Groth L; Hølmer G; Hansen HS; Fullerton A Skin Pharmacol Appl Skin Physiol; 2002; 15(6):401-13. PubMed ID: 12476014 [TBL] [Abstract][Full Text] [Related]
12. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy. Yamamoto T; Nishioka K Skin Pharmacol Appl Skin Physiol; 2003; 16(1):50-8. PubMed ID: 12566829 [TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation. Körver JE; Vissers WH; van Rens DW; Pasch MC; van Erp PE; Boezeman JB; van De Kerkhof PC Br J Dermatol; 2007 Jan; 156(1):130-7. PubMed ID: 17199579 [TBL] [Abstract][Full Text] [Related]
14. K16 expression in uninvolved psoriatic skin: a possible marker of pre-clinical psoriasis. Bhawan J; Bansal C; Whren K; Schwertschlag U; J Cutan Pathol; 2004 Aug; 31(7):471-6. PubMed ID: 15239676 [TBL] [Abstract][Full Text] [Related]
15. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes. Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488 [TBL] [Abstract][Full Text] [Related]
16. A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center. Dutz JP; Lui H Int J Dermatol; 1998 Jan; 37(1):51-3. PubMed ID: 9522242 [TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments. van Erp PE; Rijzewijk JJ; Boezeman JB; Leenders J; de Mare S; Schalkwijk J; van de Kerkhof PC; Ramaekers FC; Bauer FW Am J Pathol; 1989 Nov; 135(5):865-70. PubMed ID: 2479273 [TBL] [Abstract][Full Text] [Related]
18. Effects of Mahonia aquifolium ointment on the expression of adhesion, proliferation, and activation markers in the skin of patients with psoriasis. Augustin M; Andrees U; Grimme H; Schöpf E; Simon J Forsch Komplementarmed; 1999 Apr; 6 Suppl 2():19-21. PubMed ID: 10352377 [TBL] [Abstract][Full Text] [Related]
19. Novel functional multiparameter flow cytometric assay to characterize proliferation in skin. Mommers JM; Goossen JW; van De Kerkhof PC; van Erp PE Cytometry; 2000 Feb; 42(1):43-9. PubMed ID: 10679742 [TBL] [Abstract][Full Text] [Related]